Skip to content.

Metabolic Syndrome Institute

You are here: Home » News » Fat cell enlargement as an independent marker of insulin resistance in non-diabetic subjects


Fat cell enlargement as an independent marker of insulin resistance in non-diabetic subjects

Document Actions
  • Print this page
2007-feb-03

To examine whether fat cell size in human adipose tissue is independently related to insulin action and adipokine levels, fat cells were prepared from abdominal subcutaneous biopsies of 49 type 2 diabetic and 83 non-diabetic subjects and from omental biopsies of 37 non-diabetic subjects. Insulin sensitivity in vivo was assessed with euglycaemic-hyperinsulinaemic clamps. Fat cell enlargement was associated with insulin resistance independently of BMI in non-diabetic patients, but not in diabetic patients. Subcutaneous fat cell size correlated positively with plasma levels of leptin in both groups, but with none of the other adipokines. In non-diabetic subjects, omental fat cell size was negatively correlated with insulin action in subcutaneous, but not omental, fat cells in vitro. The results suggest that once a type 2 diabetes phenotype is established, other factors than fat cell size modulate insulin resistance.

Abstract

Ongoing Trials
Metabolic Syndrome Institute Landmark Studies
Guidelines
Metabolic Syndrome Institute Guidelines
Cardiovascular risks calculators
Metabolic Syndrome Institute Cardiovascular risks calculators
How to measure your waistline ?
Metabolic Syndrome Institute Measure your waistline
MSI Meeting
Newsletter

Metabolic Syndrome Institute Newsletter
MSI special session at WCC 2008
Web Conference
Metabolic Syndrome Institute Web Conferences
MSI 2007 Awards winners
Awards
Metabolic Syndrome Institute AWARDS
 

This site conforms to the following standards: